A case-control study on the impact of cytochrome P450 2E1 and 1A1 gene polymorphisms on the risk of lung cancer of the Han nationality in Guangzhou district

Chinese Journal of Lung Cancer

Volumn 9, Issue 6, 2006, Pages 497-501

  Wang, Dequan ^a   Chen, Sidong ^a   Wang, Baoguo ^a   Zhou, Weiping ^a  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Case control study; Cytochrome P450; Lung neoplasms; PCR; Polymorphism

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 2E1;

ARTICLE; BLOOD SAMPLING; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN FOLDING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 33846023349     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Gu YF, Zhang SC, Lai BT, et al. Relationship between genetic polymorphism of metabolizing enzymes and lung cancer susceptibity. Chin J Lung Cancer, 2003, 7(2):112-117.
2. Yin LH, Pu YP, Lin PP, et al. NQO1, CYP1A1, mEH genotype polymorphisms and susceptibility to lung cancer in Nanjing population. Tumor, 2002, 22(1):14-16.
3. Liang GY, Pu YP, Yin LH. Studies of the Genes Related to Lung Cancer Susceptibility in Nanjing Han Population, China. Hereditas (Beijing), 2004, 26(5):584-588.
4. Li DR, Zhou QH. Advance in studies on genetic susceptibility of lung cancer. Chin J Lung Cancer, 2003, 6(2):158-162.
5. Ji L, Pan S, Wu J, et al. Genetic polymorphisms of CYP2D6 in Chinese mainland. Chin Med J (Engl), 2002, 115(12):1780-1784
6. Dong CT, Yang Q, Wang MZ, et al. A study on the relationship between polymorphism of CYP1A1, lack of GSTM1 and susceptibility to lung cancer. J Labour Med, 2004, 21(6):440-442.
7. Guo ZL, Zhou QH, Zhu W, et al. A case-control study on the association between genetic polymorphisms of metabolizing enzymes CYP2D6 and susceptibility to lung cancer. Chin J Lung Cancer, 2005, 8(2):89-94.
8. Uematsu F, Ikawa S, Kikuchi H, et al. Restriction fragment length polymorphism of the human CYP2E1 (cytochrome P450 II E1) gene and susceptibility to lung cancer: possible relevance to low smoking exposure. Pharmacogenetics, 1994, 4(2):58-63.
9. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, et al. The human CYP2E1 gene and lung cancer: Dra I and Rsa I restriction fragment length polymorphisms in a Finnish study population. Carcinogenesis, 1993, 14(1):85-88.
10. Gu YF, Zhang SC, Lai BT, et al. Frequency of CYP2A6 gene deletion and its relation to risk of lung cancer. Chin J Lung Cancer, 2005, 8(4):297-299.